STOCK TITAN

TransAct investor holds 5.1% stake, eyes board changes

Investor Charles M. Gillman reports a 5.1% stake in TACT and signals potential engagement on BOHA strategy and board composition.

(High)
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

TRANSACT TECHNOLOGIES INC (TACT) received an amended Schedule 13D filing from investor Charles M. Gillman, who reports beneficial ownership of 521,841 shares of common stock, representing 5.1% of the company based on 10,276,279 shares outstanding as of April 30, 2026.

Gillman acquired these shares for an aggregate purchase price of approximately $2,453,646 and states the investment is for ordinary-course investment purposes, while reserving the right to buy or sell more shares. He indicates he may engage with other shareholders and the board about TransAct’s operations, particularly the BOHA business, and raises the possibility of shareholders calling a special meeting to elect additional directors, including supporting Daniel Friedberg as board chair.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Shares beneficially owned 521,841 shares Common stock of TransAct Technologies reported by Charles M. Gillman
Ownership percentage 5.1% Portion of TransAct Technologies common stock beneficially owned by Gillman
Shares outstanding 10,276,279 shares TransAct Technologies common stock outstanding as of April 30, 2026
Aggregate purchase price $2,453,646 Total paid by Gillman for 521,841 shares, excluding brokerage commissions
Sole voting power 521,841 shares Shares for which Gillman has sole voting power
Sole dispositive power 521,841 shares Shares for which Gillman has sole dispositive power
Date of event September 10, 2026 Date of the event requiring the amended Schedule 13D filing
Schedule 13D regulatory
"If the filing person has previously filed a statement on Schedule 13G"
A Schedule 13D is a legal document that investors file with regulators when they buy a large enough stake in a company to potentially influence its management or decisions. It provides details about the investor’s intention, ownership stake, and plans, helping other investors understand who is gaining control and what their motives might be.
Beneficially Owned financial
"Number of Shares Beneficially Owned by Each Reporting Person With"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Dispositive Power financial
"Sole Dispositive Power 521,841.00"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
extraordinary corporate transaction regulatory
"may result in any of the following: the acquisition by persons of additional Common Stock of the Issuer, an extraordinary corporate transaction involving the Issuer"
special meeting of shareholders regulatory
"call a special meeting of shareholders for the purpose of electing additional members"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What ownership stake in TACT does Charles M. Gillman report in this Schedule 13D/A?

Charles M. Gillman reports beneficial ownership of 521,841 shares of TransAct Technologies common stock, representing 5.1% of the outstanding shares, based on 10,276,279 shares outstanding as of April 30, 2026.

How much has Charles M. Gillman invested in TACT shares according to the filing?

The filing states that the aggregate purchase price of the 521,841 TransAct Technologies shares is approximately $2,453,646, excluding brokerage commissions.

What is the stated purpose of Charles M. Gillman’s investment in TACT?

Gillman states the TransAct Technologies investment is for investment purposes in the ordinary course of business. He may buy more or sell some or all of his shares over time based on market conditions, liquidity needs, and other investment considerations.

What board or governance changes does Gillman suggest for TACT?

Gillman indicates it is important for the board to add multiple new directors with relevant skills for reviewing BOHA strategic alternatives and states that Daniel Friedberg, whom he believes effectively owns more stock than other directors, should be made board chairman.

What actions regarding a special meeting of TACT shareholders are mentioned?

Gillman states his belief that TransAct’s bylaws allow shareholders holding a majority of voting rights to call a special meeting and says shareholders should consider whether to call such a meeting to elect additional board members.

What specific business area of TACT does Gillman focus on in this filing?

Gillman focuses on TransAct’s BOHA business, stating his belief that it faces unique and complicated challenges and that this requires an immediate and urgent review, including exploration of strategic alternatives for BOHA.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





892918103

(CUSIP Number)
Hitchcock Law Firm PLLC
5614 Connecticut Avenue, N.W., No. 304
Washington, DC, 20015
(202) 489-4813

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
09/10/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
Percent of class is calculated based on 10,276,279 shares of common stock, par value $0.01 (the "Common Stock"), of TransAct Technologies, Inc. (the "Issuer") outstanding as of April 30, 2026, as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission (the "SEC") on May 13, 2026 (the "10-Q").


SCHEDULE 13D


Charles M. Gillman
Signature:/s/ Charles M Gillman
Name/Title:Executive Managing Director
Date:09/10/2026

Keep reading